Abstract

Tau protein levels in cerebrospinal fluid (CSF-tau) were determined in 29 patients with old cerebrovascular disease (CVD, 21 demented and eight non-demented), 69 patients with Alzheimer's disease (AD) and 17 age-matched normal controls. The CSF-tau level in the vascular dementia (VD) group (24.0±17.0 pg/ml) was significantly lower ( P<0.0001) than that in the AD group (90.0±45.3 pg/ml), but not significantly different from that in the non-demented patients with CVD (18.1±10.2 pg/ml) or controls (20.3±13.0 pg/ml). Among the VD patients, 1/21 exceeded a cut-off value (mean±2 SD of controls), whereas 8/69 of the AD patients had CSF-tau levels below this value. These findings suggest that VD constitutes a group of dementias that can be separated from AD by normal CSF-tau levels. CSF-tau determinations in combination with other clinical findings may provide another diagnostic aid in the differential diagnosis between VD and AD.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call